As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
19 Analysts have issued a SCHOTT Pharma forecast:
19 Analysts have issued a SCHOTT Pharma forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 986 986 |
3%
3%
|
|
| Gross Profit | 332 332 |
3%
3%
|
|
| EBITDA | 266 266 |
10%
10%
|
|
| EBIT (Operating Income) EBIT | 187 187 |
5%
5%
|
|
| Net Profit | 146 146 |
2%
2%
|
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
| Head office | Germany |
| CEO | Andreas Reisse |
| Employees | 4,775 |
| Founded | 2022 |
| Website | www.schott-pharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


